Home Bollywood Irrfan Khan is not undergoing any Ayurvedic treatment for his Neuroendocrine Tumor, says spokesperson

Irrfan Khan is not undergoing any Ayurvedic treatment for his Neuroendocrine Tumor, says spokesperson

2 min read
0
0
25


Few days ago, Bollywood actor Irrfan Khan revealed that he is suffering from NeuroEndocrine Tumour. In his statement on Twitter, he also revealed that he is going out of the country to undergo treatment.

Earlier, it was being said that the actor is undergoing Ayurvedic treatment. However, Irrfan’s spokesperson has denied all such claims in their latest official statement.

His spokesperson released a statement stating: “As suggested by recent news reports, Mr. Khan is not consulting with Vaidya Balendu Prakash. He at one point had contacted him but other than one phone call there has been no conversation or consultation whatsoever. It is unacceptable to be using someone’s illness for your own publicity and personal gain.”

window.__ventunoplayer = window.__ventunoplayer||[];
window.__ventunoplayer.push({publisher_key : ‘5910141c55c44’, slot_id : ‘791’, holder_id : ‘vt-editorial-player’, player_type: ‘ep’});

The statement also requested fans to refrain from speculating about Irrfan’s health and his ongoing treatment, apparently in London. “Like irrfan khans previous statements, we all need to respect the space asked for and wait for him or his wife’s statement for any further update.”

The actor is currently in London undergoing treatment.

Meanwhile, on the work front, Irrfan will soon be seen in his upcoming film Blackmail, which is slated to release on April 6, 2018.

Read All Latest Update It BollywoodPapa.



Source link

قالب وردپرس

Load More Related Articles
Load More By user
Load More In Bollywood

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also

‘Shakti Astitva Ke Ehsaas Ki’ actress Rubina Dilaik gets engaged to beau Abhinav Shukla, flaunts her ring

.CM_BP_AP_Responsive { width: 320px; height: 100px; } @media (min-width:300px) { .CM_BP_AP…